A simple, inexpensive diagnostic tool DARC (Detection of Apoptosing Retinal Cells) has been developed. In clinical trials it allowed for the first time visualization of individual nerve cell death in patients with glaucoma. Early detection means doctors can start treatments before sight loss begins. Ongoing trials are investigating the potential of the test for other neurodegenerative conditions.
Glaucoma affects 60 million people in the world, with 1 in 10 suffering total sight loss in both eyes. Early detection means doctors can start treatments before sight loss begins...
Read More
Recent Comments